Petrov2018 - C-547 a 6-methyluracil derivative with long-lasting binding and rebinding on acetylcholinesterase Lab
About lab
C-547, a candidate drug, is a potent slow-binding inhibitor of acetyl-cholinesterase, and the focus of this PK/PD model, which investigates the metabolism and clinical effect of C-547 when it is no lo. It can be used to explore dose-response dynamics and compare treatment scenarios across conditions.
Runtime
Duration60
Comms Step2
Runs
Total0
Completed0
Failed0
Metadata
Packagepetrov2018-c-547-a-6-methyluracil-derivative-with-long-lasting-b
Created2026-05-16
Updated2026-05-16
pharmacologyreceptor-bindingneurosciencetoxicologysbmltelluriumfaithfulbiomodels_ebivisualisation
Manifest
{
"io": {
"inputs": [
{
"name": "initial_c547_binding_state_y1",
"label": "Initial C547 Binding State Y1",
"maps_to": "pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model.initial_c547_binding_state_y1"
},
{
"name": "initial_c547_binding_state_y2",
"label": "Initial C547 Binding State Y2",
"maps_to": "pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model.initial_c547_binding_state_y2"
},
{
"name": "initial_c547_binding_state_y3",
"label": "Initial C547 Binding State Y3",
"maps_to": "pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model.initial_c547_binding_state_y3"
},
{
"name": "initial_c547_binding_state_y4",
"label": "Initial C547 Binding State Y4",
"maps_to": "pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model.initial_c547_binding_state_y4"
},
{
"name": "initial_c547_binding_state_y5",
"label": "Initial C547 Binding State Y5",
"maps_to": "pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model.initial_c547_binding_state_y5"
}
],
"outputs": [
{
"name": "state",
"label": "Tracked source state",
"maps_to": "pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model.state"
},
{
"name": "summary",
"label": "Simulation summary",
"maps_to": "pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model.summary"
},
{
"name": "species_labels",
"label": "Observable labels",
"maps_to": "pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model.species_labels"
},
{
"name": "c547_binding_state_y1",
"label": "C547 Binding State Y1",
"maps_to": "pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model.c547_binding_state_y1"
},
{
"name": "c547_binding_state_y2",
"label": "C547 Binding State Y2",
"maps_to": "pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model.c547_binding_state_y2"
},
{
"name": "c547_binding_state_y3",
"label": "C547 Binding State Y3",
"maps_to": "pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model.c547_binding_state_y3"
},
{
"name": "c547_binding_state_y4",
"label": "C547 Binding State Y4",
"maps_to": "pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model.c547_binding_state_y4"
},
{
"name": "c547_binding_state_y5",
"label": "C547 Binding State Y5",
"maps_to": "pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model.c547_binding_state_y5"
}
]
},
"tags": [
"pharmacology",
"receptor-binding",
"neuroscience",
"toxicology",
"sbml",
"tellurium",
"faithful",
"biomodels_ebi"
],
"title": "Petrov2018 - C-547 a 6-methyluracil derivative with long-lasting binding and rebinding on acetylcholinesterase Lab",
"models": [
{
"path": "owned/models/pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model",
"alias": "pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model",
"parameters": {
"model_path": "data/MODEL1910240001.xml",
"integration_step": 0.2
},
"provenance": {
"owned_path": "owned/models/pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model"
}
},
{
"path": "owned/models/visualisation",
"alias": "visualisation",
"provenance": {
"owned_path": "owned/models/visualisation"
}
}
],
"wiring": [
{
"to": [
"visualisation.pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model_state"
],
"from": "pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model.state"
},
{
"to": [
"visualisation.pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model_summary"
],
"from": "pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model.summary"
},
{
"to": [
"visualisation.pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model_species_labels"
],
"from": "pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model.species_labels"
}
],
"runtime": {
"duration": 60,
"initial_inputs": {},
"communication_step": 2
},
"description": "C-547, a candidate drug, is a potent slow-binding inhibitor of acetyl-cholinesterase, and the focus of this PK/PD model, which investigates the metabolism and clinical effect of C-547 when it is no lo. It can be used to explore dose-response dynamics and compare treatment scenarios across conditions.",
"schema_version": "2.0"
}Sign in to start your own run. Public-lab history stays visible here.
Select a run from History to view its results.